Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01622751|
Recruitment Status : Completed
First Posted : June 19, 2012
Last Update Posted : June 19, 2012
Context: Adiponectin is an adipose tissue-derived hormone with an insulin sensitizing effect, and has been related to obstructive sleep apnea syndrome. In addition, children with Prader-Willi syndrome (PWS) suffer from excessive daytime sleepiness and the abnormality of rapid eye movement (REM) sleep.
Objective: To determine if the sleep stages are related to the plasma levels of adiponectin, resistin, and RBP4 (retinol binding protein-4), and whether these relationships are influenced by age, obesity and insulin resistance.
|Condition or disease|
|Prader-Willi Syndrome Obesity|
|Study Type :||Observational|
|Actual Enrollment :||46 participants|
|Observational Model:||Case Control|
|Official Title:||Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome|
|Study Start Date :||January 2007|
|Actual Study Completion Date :||June 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01622751
|Principal Investigator:||Dong-Kyu Jin, M.D.||Samsung Medical Center, Sungkyunkwan University School of Medicine|